Fampyra is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability. Fampyra is a medicine that contains the active substance fampridine. It is available as prolonged-release tablets (10 mg). Fampyra (fampridine) was approved for multiple sclerosis (MS) by: The Food and Drug Administration (FDA), US, January 2010, Therapeutic Goods Administration (TGA), Australia, May 2011, European Medicines Agency (EMA), EU, July 2011, commercialised under the brand name Fampyra (fampridine)and Health Canada, February 2012

Where can I buy Fampyra Tablets?

Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow and Pune and other cities in India. with over 20 years of domain experience.

The order for Fampyra (Fampridin) Tablets will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

For Fampyra or Fampridin Tablets price in India. Please call at M: +91 9811747774 or Email Us to know more details about the medicine and its cost price in India.
Fampyra (Fampridin) Tablets

Get In Touch

Facilitator under Patient Assistance Programs In India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Fampyra (Fampridin) on prescription and Import License in Patient's Name only.

For overseas patients, Fampyra (Fampridin) Tablets can be made available in Send your enquiry to find Fampyra (Fampridin) Tablets in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.